In addition, IL-10, TGF-β, and PGE2 can inhibit the maturation of dendritic cells and the expression of MHC II and B7 co-stimulating molecules on their surface, thereby influencing the recognition of the tumor. This evidence concerns the gene TGFB1 and neoplasm.